---
title: "Pregabalin for Treatment-Resistant Generalised Anxiety Disorder: Statistical Analysis Plan for the"
id: "medrxiv-16-pregabalin-for-treatment-resistant-generalised-anxiety-disorder-statistical"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-pregabalin-for-treatment-resistant-generalised-anxiety-disorder-statistical"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1?rss=1"
published_at: "2026-09-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Pregabalin for Treatment-Resistant Generalised Anxiety Disorder: Statistical Analysis Plan for the
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-pregabalin-for-treatment-resistant-generalised-anxiety-disorder-statistical
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1?rss=1)
- **Published At:** 2026-09-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The document is the pre-specified Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial evaluating **pregabalin** in people with **generalised anxiety disorder** (GAD) who are treatment resistant. - PETRA compares **pregabalin** plus an antidepressant and standard care versus placebo plus an antidepressant and standard care, with the primary outcome being the **GAD-7** score at week 12. - Trial registration is provided: ISRCTN16993990. The SAP is intended to govern analysis of the primary endpoint and related analyses prior to database lock and unblinding. - Ethical approval was granted by The East Midlands - Leicester Central Research Ethics Committee (REC reference: 23/EM/0192); authors confirm participant consent and adherence to reporting guidelines. - The authors declare no competing interests. - The study is funded by the National Institute for Health and Care Research, Health Technology Assessment (NIHR HTA), grant number 134074. - The manuscript reports that no datasets were generated or analysed for this SAP paper; it is a pre-specified plan rather than trial results. - The SAP document authors are Glyn Lewis, Nicholas Freemantle, Hakim-Moulay Dehbi, Charlotte Clarke, and Ekaterina Bordea (University College London). - The preprint was posted on medRxiv on September 04, 2026 and is available under a CC-BY 4.0 license. - The SAP’s detailed statistical methods, analytic populations, handling of missing data, and specific model specifications are described in the source SAP document; where specifics are not reported in the current abstract/metadata, those details are not restated here.
## Clinical Analysis & Structured Key Points
PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial | medRxiv Skip to main content PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial Glyn Lewis , Nicholas Freemantle , Hakim-Moulay Dehbi , Charlotte Clarke , Ekaterina Bordea doi: https://doi.org/10.64898/2026.09.01.26359217 Glyn Lewis University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: glyn.lewis{at}ucl.ac.uk Nicholas Freemantle University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hakim-Moulay Dehbi University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site Charlotte Clarke University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ekaterina Bordea University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract This document describes the Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial in people with generalised anxiety disorder comparing pregabalin plus an antidepressant and standard care, with placebo plus an antidepressant and standard care, with respect to the primary outcome of the GAD-7 score at week 12. Competing Interest Statement The authors have declared no competing interest. Clinical Trial ISRCTN16993990 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The East Midlands - Leicester Central Research Ethics Committee of the Health Research Authority gave ethical approval for this work (REC reference: 23/EM/0192). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability No datasets were generated or analysed during the current study. This manuscript describes the pre-specified statistical analysis plan for the PETRA trial. Funder Information Declared National Institute for Health and Care Research, Health Technology Assessment (NIHR HTA) , 134074 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 04, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial Glyn Lewis , Nicholas Freemantle , Hakim-Moulay Dehbi , Charlotte Clarke , Ekaterina Bordea medRxiv 2026.09.01.26359217; doi: https://doi.org/10.64898/2026.09.01.26359217 Share This Article: Copy Citation Tools PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial Glyn Lewis , Nicholas Freemantle , Hakim-Moulay Dehbi , Charlotte Clarke , Ekaterina Bordea medRxiv 2026.09.01.26359217; doi: https://doi.org/10.64898/2026.09.01.26359217 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (615) Allergy and Immunology (896) Anesthesia (327) Cardiovascular Medicine (4777) Dentistry and Oral Medicine (476) Dermatology (410) Emergency Medicine (645) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1617) Epidemiology (15853) Forensic Medicine (32) Gastroenterology (1196) Genetic and Genomic Medicine (6996) Geriatric Medicine (727) Health Economics (1059) Health Informatics (4999) Health Policy (1428) Health Systems and Quality Improvement (1742) Hematology (583) HIV/AIDS (1338) Infectious Diseases (except HIV/AIDS) (16251) Intensive Care and Critical Care Medicine (1163) Medical Education (665) Medical Ethics (151) Nephrology (721) Neurology (7208) Nursing (365) Nutrition (1074) Obstetrics and Gynecology (1233) Occupational and Environmental Health (1002) Oncology (3581) Ophthalmology (1039) Orthopedics (394) Otolaryngology (448) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1782) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5846) Public and Global Health (9705) Radiology and Imaging (2392) Rehabilitation Medicine and Physical Therapy (1436) Respiratory Medicine (1245) Rheumatology (635) Sexual and Reproductive Health (769) Sports Medicine (577) Surgery (769) Toxicology (107) Transplantation (303) Urology (287)
## Related Clinical Research

- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)
- [Heterogeneity in Excess Mortality by Diagnosis, Care Setting, and Substance Use in Finland Cohort](https://medichelpline.com/clinical-feed/medrxiv-17-heterogeneity-in-excess-mortality-across-mental-behavioural-and.md)
- [Household hunger trajectories and mental health symptoms in adolescent girls and young women in ru](https://medichelpline.com/clinical-feed/medrxiv-23-household-hunger-trajectories-and-mental-health-symptoms-of-adolescent-girls.md)
- [DSM-6 should include algorithmic and social media exposure in eating disorder assessments](https://medichelpline.com/clinical-feed/stat-news-2-opinion-the-next-dsm-should-address-the-algorithm-s-role-in-eating-disorders.md)
- [Serum vitamin D (25[OH]D) and Morse Fall Scale risk in hospitalized adults](https://medichelpline.com/clinical-feed/plos-one-18-serum-vitamin-d-levels-and-fall-risk-in-adults-a-cross-sectional-study-using.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.